AXIS Participaciones Empresariales

DeepUll is a biotechnology company dedicated to developing an innovative diagnostic system for early-stage sepsis. The company's approach focuses on rapidly identifying pathogens and delivering antibiogram results within hours. By utilizing artificial intelligence, DeepUll is able to determine the infective agent and provide insights into antimicrobial susceptibility, which helps reduce unnecessary antibiotic use. This system not only enables quick detection of pathogens and antibiotic resistance without the need for prior cultivation but also allows healthcare providers to assess a patient's immunological and functional status. Consequently, DeepUll's technology empowers doctors to predict the onset and progression of sepsis, facilitating timely clinical interventions even before symptoms manifest.

Vivira is dedicated to making physical rehabilitation accessible to a broad audience through its innovative mobile orthopedic training application. This application provides personalized training programs that users can follow at home, beginning with a one-month assessment of their agility, strength, and coordination. Based on this assessment, the application develops a customized exercise regimen that gradually increases in intensity, allowing patients to manage their pain and restore physical functions independently. By tracking performance regularly, Vivira ensures that users receive ongoing support in their rehabilitation journey.

Cabify is a ride-sharing company founded in 2011 and headquartered in Madrid, Spain. It connects private users and businesses with transportation options that meet their needs, focusing on enhancing the overall travel experience for both passengers and drivers. The company offers on-demand services that include clean, modern vehicles equipped with amenities such as music, magazines, and water, all driven by specially trained drivers. Cabify emphasizes affordability, safety, and reliability in its rides, aiming to improve mobility in urban areas and contribute positively to the communities it serves. By prioritizing customer satisfaction and accessibility, Cabify seeks to redefine transportation in cities.

DeepUll is a biotechnology company dedicated to developing an innovative diagnostic system for early-stage sepsis. The company's approach focuses on rapidly identifying pathogens and delivering antibiogram results within hours. By utilizing artificial intelligence, DeepUll is able to determine the infective agent and provide insights into antimicrobial susceptibility, which helps reduce unnecessary antibiotic use. This system not only enables quick detection of pathogens and antibiotic resistance without the need for prior cultivation but also allows healthcare providers to assess a patient's immunological and functional status. Consequently, DeepUll's technology empowers doctors to predict the onset and progression of sepsis, facilitating timely clinical interventions even before symptoms manifest.

Volotea S.A. is a low-cost airline based in Barcelona, Spain, founded in 2012. The airline specializes in providing direct flights between small and medium-sized cities across Europe, catering to travelers seeking convenient and affordable transportation options. In addition to air travel, Volotea also offers car rental and hotel booking services to enhance the overall travel experience. The company has experienced significant growth, regularly expanding its fleet, increasing the number of routes, and adding more seats to accommodate rising demand. Volotea aims to create a welcoming atmosphere for its passengers, positioning itself as one of the fastest-growing independent airlines in Europe.

SATLANTIS is a company specializing in the design and manufacture of high-performance Earth observation payloads for small satellites, operating from both Spain and Florida. It focuses on developing advanced microsatellite technology, including its flagship product, the Integrated Standard Imager for Earth Observation Microsatellites (iSIM). This optical imaging system is tailored for microsatellites weighing between 20 to 75 kilograms, delivering exceptional performance and flexibility at a reduced cost compared to traditional Earth observation instruments. SATLANTIS aims to foster collaboration among universities, industries, and government agencies to enhance the utilization of microsatellite constellations for scientific and commercial purposes. The company is also forming partnerships in the U.S. and Europe to establish the necessary infrastructure for the manufacture, integration, launch, and operation of standardized microsatellites, while leveraging AI-enabled payloads to enhance remote sensing capabilities and provide clients with high-resolution Earth observation services.

Avanza Externalización de Servicios is a Spanish multinational specializing in outsourcing of services and processes.

Oncovision (GEM Imaging S.A.) is a Spanish technologic start-up company created in 2003 with the initiative of the Corpuscular Physics Institute (CSIC) and the University of Valencia. They work in Molecular Vision applied to Health Sciences focusing in: cancer diagnosis and treatment, and advanced research in neurology, oncology, and cardiology. They are a company focused on Molecular Vision, which creates, develops and markets new medical technologies, global innovations with relevant clinical and economic advantages, often representing a breakthrough in current standards of diagnosis and treatment. ONCOVISION´s original, fresh technology, strong intellectual property, top-level clinical evidence, leading global reference centers, and pioneering protocols, is supported by its dynamic cross-functional team. ONCOVISION is opening unprecedented options in the treatment of cancer and serious cardiac and neurological diseases. Their team and the company’s technologies have been recognized by Spanish and European prestigious institutions. In 2007, the company was selected as one of the “20 Best Technologic Companies in Spain” and won the “National Medical Physics 2007 Congress Award” In 2008, it was one of the “20 Best Health Technology Companies in Europe” by the prestigious European Technology Tour, as well as finalist in the “National 25th Aniversary Enisa Award” Prof. Jose María Benlloch, active member of the company, won in 2008, the well-known “Jaime I” award. Scientists, technicians, and technologists of ONCOVISION have dozens of publications and presentations at scientific and medical conferences worldwide. Their shareholding, based in Valencia, was strengthened in August 2006 by the Spanish venture capital firm Bullnet, unifying its proven track in technological and management capabilities with companies in Spain and Portugal. The company is managed by a multi-task professional team with international experience. With proven clinical and scientific results, differentiated technology with enormous potential for future technological and financial capacity, intellectual property and developing lines, ONCOVISION is today ahead in the Spanish and European Health Industry.

Industrias H. Pardo manufactures and markets hospital and nursing, geriatric, and home beds and furniture. The company offers armchairs, bedside tables, cranes, cribs, accessories, mattresses, covers, and pillows. It serves customers in Spain and internationally.

ERA Biotech specializes in the development and implementation of advanced cell-based biomanufacturing technologies. The company utilizes its proprietary tools, Zera and StorPro, to enhance performance in standard eukaryotic culture systems, which are widely used for the production of protein drugs, enzymes, and other biological products. Additionally, ERA Biotech focuses on biotechnology research, leveraging its technologies to create innovative solutions for existing enzymes and novel recombinant and plasmid DNA vaccines. The firm aims to deliver significant advancements in protein-cleavage and purification systems, positioning itself as a key player in the biotechnology sector.

It is one of the largest companies in the Spanish biotechnology sector. Its activity focuses on research, development and commercialization of biotechnology services. Born in 2000 under the initiative of a group of researchers of the Higher Council for Scientific Research (CSIC) and business professionals and is one of four companies in the business group Bionostra.

Philips Indal is a manufacturer of lighting systems that specializes in the design, production, and installation of LED lighting products. The company offers a diverse range of outdoor lighting solutions in markets such as Brazil, France, Hong Kong, South Africa, and Australia, while providing indoor lighting products in Portugal and the Middle East. Additionally, Philips Indal develops horticultural lighting solutions for customers in Russia and Canada. With operations in over 50 countries, the company is committed to delivering innovative lighting systems, including smart technologies and energy-efficient options, to meet the varying needs of its global clientele.